Financially vulnerable people fall victim to the pharmaceutical companies' tests

In high-income countries, pharmaceutical research is highly regulated, while in low-income countries there is often a lack of clear ethical regulations.
The Corona pandemic has sparked discussions about whether new vaccines and medicines should be tested in low-income countries. It is a historical trend that drug research is carried out on economically disadvantaged people, while it is the richer people who ultimately have access to the medicines.
May 11, 2020, Report